Skip to main content
SpringerLink
Log in

Progress in New Markers for Diabetes Inflammation

  • Chapter
Inflammatory Pathways in Diabetes

Part of the book series: Progress in Inflammation Research ((PIR))

  • 989 Accesses

Abstract

Biochemical markers indicative of disease and cellular processes in diabetes are surveyed against existing clinical utility. Markers are categorized by indications for hyperglycemic stress, oxidative stress, and inflammation. The adipokines and fatty acid metabolism markers are further surveyed as diabetic stress measures during obesity. Inflammation markers are separated by those indicative of adipose stress, those providing insight into endothelial dysfunction, and those indicating innate immunity activation. Prognostic and diagnostic values are compared to state of art and ideal marker needs. Markers are separated further by key cellular pathways and pathologies. Interactions between tissues are related as a systematic approach to diabetic disease and to common therapeutic approaches. Markers of proven utility are identified along new avenues of clinical and biologic research. While new markers have uncovered factors in insulin metabolism and innate immune activation, there still remains considerable room for improvement, and there remains an unmet need for better identification of progression and monitoring of the repair processes

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agrawal NR, Kant S (2014) Targeting inflammation in diabetes: newer therapeutic options. World J Diab 5(5):697–710

    Article  Google Scholar 

  • Al-Hamodi Z et al (2011) Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovasc Diabetol 10:23

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Al-Rawi NH (2011) Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 8(1):22–28

    Article  PubMed  Google Scholar 

  • Alsaad KO, Herzenberg AM (2007) Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. Clin Pathol 60(1):18–26

    Article  CAS  Google Scholar 

  • Armstrong AM, Chestnutt JE, Gormley MJ, Young IS (1996) The effect of dietary treatment on lipid peroxidation and antioxidant status in newly diagnosed noninsulin dependent diabetes. Free Radic Biol Med 21(5):719–726

    Article  CAS  PubMed  Google Scholar 

  • Azar ST, Major SC, Safieh-Garabedian B (1999) Altered plasma levels of nerve growth factor and transformation growth factor-β 2 in type-1 diabetes mellitus. Brain Behav Immun 13(4):361–366

    Article  CAS  PubMed  Google Scholar 

  • Ballantyne GH, Gumbs A, Modlin IM (2005) Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 15(5):692–699

    Google Scholar 

  • Barry GD, Le GT, Fairlie DP (2006) Agonists and antagonists of protease activated receptors (PARs). Curr Med Chem 13(3):243–262

    Article  CAS  PubMed  Google Scholar 

  • Beavers KM, Nicklas BJ (2011) Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome. Front Biosci 3:168–177

    Article  Google Scholar 

  • Beck R et al (2011) The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Pediatr Diab 12(8):690–695

    Article  CAS  Google Scholar 

  • Black RA (2002) Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 34(1):1–5

    Article  CAS  PubMed  Google Scholar 

  • Blann AD et al (2002) Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes. Clin Sci (Lond) 102(2):187–194

    Article  CAS  Google Scholar 

  • Bourlier V et al (2012) TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages. PLoS One 7(2):e31274

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Brady EM et al (2012) Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population. Exp Diabetes Res 2012:e386041

    Article  Google Scholar 

  • Breslin WL et al (2012) Obese Mexican American children have elevated MCP-1, TNF-α, monocyte concentration, and dyslipidemia. Pediatrics 129(5):e1180–e1186

    Article  PubMed  Google Scholar 

  • Callard P (1975) Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol 80(2):329–340

    PubMed Central  CAS  PubMed  Google Scholar 

  • Carroll MC (2004a) A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 4:825–831

    Article  CAS  PubMed  Google Scholar 

  • Carroll MC (2004b) The complement system in regulation of adaptive immunity (review). Nat Immunol 3(10):981–986

    Article  CAS  Google Scholar 

  • Cawthorn WP, Sethi JK (2008) TNF-alpha and adipocyte biology. FEBS Lett 582(1):117–131

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Chandra J et al (2001) Role of apoptosis in pancreatic β cell death in diabetes. Diabetes 50(Suppl 1):S44–S47

    Article  CAS  PubMed  Google Scholar 

  • Chen HC, Farese RV (2005) Inhibition of triglyceride synthesis as a treatment strategy for obesity lessons from DGAT1-deficient mice. Arterioscler Thromb Vasc Biol 25:482–486

    Article  CAS  PubMed  Google Scholar 

  • Chiarella F, Giannini C, Mohn A (2004) Growth, growth factors and diabetes. Eur J Endocrinol 151:U109–U117

    Article  Google Scholar 

  • Cirri P et al (2005) Insulin inhibits platelet-derived growth factor-induced cell proliferation. Mol Biol Cell 16(1):73–83

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Collins T et al (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9(10):899–909

    CAS  PubMed  Google Scholar 

  • Cook SA et al (2002) Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 227:22528–22533

    Article  CAS  Google Scholar 

  • Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60(3):349–356

    Article  CAS  PubMed  Google Scholar 

  • Cross DAE et al (1997) Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett 406(1–2):211–215

    Article  CAS  PubMed  Google Scholar 

  • Descamps-Latscha B (1993) The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 2(6):883–891

    Article  CAS  PubMed  Google Scholar 

  • DeVita RJ, Pinto S (2013) Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors. J Med Chem 56(24):9820–9825

    Article  CAS  PubMed  Google Scholar 

  • Ding L (2014) Coordinated actions of FXR and LXR in metabolism: from pathogenesis to pharmacological targets for type 2 diabetes (review). Int J Endocrinol 2014;Article ID 751859, 13 pgs

    Google Scholar 

  • Doronzo G et al (2006) Insulin activates hypoxia-inducible factor-1 in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signaling. Diabetologia 49:1049–1063

    Article  CAS  PubMed  Google Scholar 

  • El Mesallamy HO (2012) Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy. Clin Biochem 45(9):646–650

    Article  PubMed  CAS  Google Scholar 

  • Ferrari G et al (2006) VEGF, a pro-survival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosis. Proc Natl Acad Sci U S A 103(46):17260–17265

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 73(4):1907–1916

    Google Scholar 

  • Flores L et al (2004) Transforming growth factor β1 at clinical onset of type 1 diabetes mellitus. A pilot study. Diabet Med 21(8):818–822

    Article  CAS  PubMed  Google Scholar 

  • Gao D et al (2014) Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. Am J Physiol Endocrinol Metab 307:E289–E304

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Garton KJ, Gough PJ, Raines EW (2006) Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 79:1105–1116

    Article  CAS  PubMed  Google Scholar 

  • Gebhart A et al (2014) Changes in high-sensitivity C-reactive protein levels after laparoscopic gastric stapling procedures versus laparoscopic gastric banding. Am Surg 80(10):1044–1048

    PubMed  Google Scholar 

  • Gerhard GS et al (2013) A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care 36(7):1859–1864

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ghosh AK, Vaughan DE (2012) PAI-1 in tissue fibrosis (review). J Cell Physiol 227(2):493–507

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gkrania-Klotsas E et al (2010) Differential white blood cell count and type 2 diabetes: systematic review and m-analysis of cross-sectional and prospective studies. PLoS One 5(10):e13405

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Goldfine AB et al (2011) Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion. Clin Chem 57(2):326–337

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Good M et al (2006) TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue – influence of BMI and adipose distribution. Diab Vasc Dis Res 3(1):26–33

    Article  PubMed  Google Scholar 

  • Goodarzi MT et al (2010) Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J Clin Lab Anal 24:72–76

    Article  CAS  PubMed  Google Scholar 

  • Gottsäter M et al (2013) Adrenomedullin is a marker of carotid plaques and intima-media thickness as well as brachial pulse pressure. J Hypertens 31(10):1959–1965

    Article  PubMed  CAS  Google Scholar 

  • Gorden P, Gavrilovay O (2003) The clinical uses of leptin. Curr Opin Pharma. 3:655–659

    Google Scholar 

  • Gumbs AA, Modlin IM, Ballantyne GH (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 15(4):462–473

    Google Scholar 

  • Halberg N et al (2009) Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29(16):4467–4483

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Haligur M, Topsakal S, Ozmen O (2012) Early degenerative effects of diabetes mellitus on pancreas, liver, and kidney in rats: an immunohistochemical study. Exp Diab Res 2012:1–10

    Article  Google Scholar 

  • Haluzik M (2005) Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. Curr Opin Investig Drugs 6(10):988–993

    CAS  PubMed  Google Scholar 

  • Holvoet P et al (1998) Oxidized LDL and malondialdehyde modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98:1487–1494

    Article  CAS  PubMed  Google Scholar 

  • Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91

    Article  CAS  PubMed  Google Scholar 

  • Hurtado O et al (2001) Up-regulation of TNF-alpha convertase (TACE/ADAM-17) after oxygen-glucose deprivation in the rat forebrain slices. Neuropharmacology 40(8):1094–1102

    Article  CAS  PubMed  Google Scholar 

  • Hwang ES, Kim GH (2007) Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 229(1–2):1–10

    Article  CAS  PubMed  Google Scholar 

  • Ichikawa Y et al (2004) The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning. Cardiovasc Res 62:167–175

    Article  CAS  PubMed  Google Scholar 

  • Il’yasova D, Scarbrough P, Spasojevic I (2012) Urinary biomarkers of oxidative status. Clin Chim Acta 413(19–20):1446–1453

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Jiang C et al (2011) Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes 60(10):2484–2495

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Johnson H et al (2003) Cell death induced by granzyme C. Blood 101(8):3093–3101

    Article  CAS  PubMed  Google Scholar 

  • Johnson AR, Milner JJ, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249(1):218–238

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kawaguchi M et al (1993) Excretion of urinary epidermal growth factor in non-insulin dependent diabetes mellitus. Life Sci 52(14):1181–1186

    Article  CAS  PubMed  Google Scholar 

  • Kern PA et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280(5):E745–E751

    CAS  PubMed  Google Scholar 

  • Kir S et al (2011) FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331(6024):1621–1624

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Knudsen SH, Karstoft K, Solomon TP (2014) Hyperglycemia abolishes meal-induced satiety by a dysregulation of ghrelin and peptide YY3-36 in healthy overweight/obese humans. Am J Physiol Endocrinol Metab 306(2):E225–E231

    Article  CAS  PubMed  Google Scholar 

  • Koistinen HA (2001) Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol 21:1034–1039

    Article  CAS  PubMed  Google Scholar 

  • Krolewski AJ et al (2012) Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23:516–524

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Lalor PF (2002) Recruitment of lymphocytes to the human liver. Immunol Cell Biol 80:52–64

    Article  CAS  PubMed  Google Scholar 

  • Lam TK et al (2002) Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am J Physiol Endocrinol Metab 283(4):E682–E691

    Article  CAS  PubMed  Google Scholar 

  • Lam JK et al (2013) Effect of insulin on the soluble receptor for advanced glycation end products (RAGE). Diabet Med 30(6):702–709

    Article  CAS  PubMed  Google Scholar 

  • Lee BC, Lee J (2014) Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 1842:446–462

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lev-Ran A et al (1990) Excretion of epidermal growth factor (EGF) in diabetes. Clin Chim Acta 192(3):201–206

    Article  CAS  PubMed  Google Scholar 

  • Lewandowski KC et al (2011) Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia. Arch Med Sci 7(2):294–303

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Li G et al (2014) The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients. Cardiovasc Diab 13:52

    Article  CAS  Google Scholar 

  • Liu Y et al (2014) Acylation stimulating protein, complement C3 and lipid metabolism in ketosis-prone diabetic subjects. PLoS One 9(10):e109237

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Lopes-Virella MF et al (2008) Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care 31:2006–2012

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lorenzo M et al (2008) Insulin resistance induced by tumor necrosis factor-a in myocytes and brown adipose. J Anim Sci 86(14 Suppl):E94–E104

    CAS  PubMed  Google Scholar 

  • Lu M et al (1999) Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci 40(13):3281–3286

    CAS  PubMed  Google Scholar 

  • Lui W (2005) Design, synthesis, and structure–activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis. Bioorg Med Chem Lett 15:4574–4578

    Article  CAS  Google Scholar 

  • Maggard-Gibbons MA et al (2013) Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 309(21):2250–2261

    Google Scholar 

  • Makishima M (2005) Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors (review). J Pharmacol Sci 97:177–183

    Article  CAS  PubMed  Google Scholar 

  • Mamane Y et al (2009) The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes 58:2006–2017

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Matsumoto K et al (2007) Inverse correlation between activated protein C generation and carotid atherosclerosis in type 2 diabetic patients. Diabet Med 24(12):1322–1328

    Article  CAS  PubMed  Google Scholar 

  • Mazzola N (2012) Review of current and emerging therapies in type 2 diabetes mellitus. Am J Manag Care 1:S17–S26

    Google Scholar 

  • Meiera U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50(9):1511–1525

    Article  CAS  Google Scholar 

  • Moreno-Navarrete JM et al (2010) Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes (Lond) 34(2):240–249

    Article  CAS  Google Scholar 

  • Motawi TMK et al (2013) Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients. BMC Endocr Disord 13:32

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72(21):1–28

    Google Scholar 

  • Patel PS, Buras ED, Balasubramanyam A (2013) The role of the immune system in obesity and insulin resistance (review articles). J Obes 2013:Article ID 616193, 9 pgs

    Google Scholar 

  • Peake PW et al (2005) Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. Int J Obes (Lond) 29(4):429–435

    Article  CAS  Google Scholar 

  • Peuchant E (1997) Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 20:202–207

    Article  CAS  PubMed  Google Scholar 

  • Phieler J, Garcia-Martin R, Lambris JD, Chavakis T (2013) The role of the complement system in metabolic organs and metabolic diseases. Semin Immunol 25(1):47–53

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pitocco D (2013) Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci 14:21525–21550

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Porasuphatana S et al (2012) Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study. Asia Pac J Clin Nutr 21(1):12–21

    CAS  PubMed  Google Scholar 

  • Preedy VR, Hunter RJ (eds) (2011) Adipokines, 1st edn. CRC Press LCC, New York, NY. pp 1–458. ISBN 9781578086894

    Google Scholar 

  • Pscherer S et al (2013) Anti-diabetic treatment regulates pro-fibrotic TGF-ß serum levels in type 2 diabetics. Diabetol Metab Syndr 5(1):1–6

    Article  CAS  Google Scholar 

  • Pugia MJ, Valdes R, Jortani SA (2007) Chapter on urinary trypsin inhibitors: structure, biological relevance and measurement. In: Makowski G (ed) Advances in clinical chemistry, vol 44. Academic Press. Elsevier, New York, NY. ISBN 10: 0-12-373704-4

    Google Scholar 

  • Qin X et al (2004) Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 53(10):2653–2661

    Article  CAS  PubMed  Google Scholar 

  • Ramakrishna V, Jailkhani R (2007) Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients. Diagn Pathol 2:22

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Ranganathan P et al (2007) Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells. BMC Genomics 8:98

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Ridker PM (2014) Plasma levels of the pro-inflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events. J Am Heart Assoc 3(3):e000897

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Roberts AC, Porter KE (2013) Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vasc Dis Res 10(6):472–482

    Article  PubMed  CAS  Google Scholar 

  • Rosenberger C et al (2008) Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 73(1):34–42

    Article  CAS  PubMed  Google Scholar 

  • Sasaki A et al (2014) Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne). 5;164

    Google Scholar 

  • Satoh N (2004) Leptin to adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27(10):2488–2490

    Article  CAS  PubMed  Google Scholar 

  • Scheving LA et al (2002) Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem Biophys Res Commun 290(1):197–203

    Article  CAS  PubMed  Google Scholar 

  • Schulze M et al (1993) Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 142(1):179–187

    PubMed Central  CAS  PubMed  Google Scholar 

  • Seedorf K (1995) Intracellular signaling by growth factors. Metabolism 44:24–32

    Article  CAS  PubMed  Google Scholar 

  • Seet RC et al (2010) Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. Diabetes Care 33(5):1140–1142

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shiau MY et al (2006) Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med 73(7):1024–1028

    PubMed  Google Scholar 

  • Siddle K (2011) Signaling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol 47:R1–R10

    Article  CAS  PubMed  Google Scholar 

  • Soares JB, Roncon-Albuquerque R, Leite-Moreira A (2008) Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity. Expert Opin Ther Targets 12(9):1177–1189

    Article  CAS  PubMed  Google Scholar 

  • Soni SS et al (2009) Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 28:165–174

    Article  CAS  PubMed  Google Scholar 

  • Sorisky A, Magun R, Gagnon AM (2000) Adipose cell apoptosis: death in the energy depot. Int J Obes 24(4):S3–S7

    Article  CAS  Google Scholar 

  • Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE (2004) Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53(8):2079–2086

    Article  CAS  PubMed  Google Scholar 

  • Subauste A, Burant CF (2003) DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus. Curr Drug Targets 3:263–270

    Article  CAS  Google Scholar 

  • Sun K et al (2013) Fibrosis and adipose tissue dysfunction. Cell Metab 18(4):470–477

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sung CC, Hsu YC, Chen CC, Lin YF, Wu CC (2013) Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxid Med Cell Longev 2013:Article ID 301982, 15 pgs

    Article  CAS  Google Scholar 

  • Suzuki T et al (2014) Hypoxia and fatty liver. World J Gastroenterol 20(41):15087–15097

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Szalai AJ (2004) C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clin Dev Immunol 11(3–4):221–226

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Szmitko PE et al (2003a) Biomarkers of vascular disease linking inflammation to endothelial activation: part 2. Circulation 108:2041–2048

    Article  PubMed  Google Scholar 

  • Szmitko PE et al (2003b) Biomarkers of vascular disease linking inflammation to endothelial activation: part 1. Circulation 108:1917–1923

    Article  PubMed  Google Scholar 

  • Trakhtenbroit MA et al (2009) Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of baraitric surgery. Am J Med. 122(5):435–442

    Google Scholar 

  • Travers RL et al (2015) The impact of adiposity on adipose tissue-resident lymphocyte activation in humans. Int J Obes (Lond) 39(8):762–769

    Google Scholar 

  • Tsuriya D et al (2011) Significant correlation between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects. Intern Med 50:2767–2773

    Article  CAS  PubMed  Google Scholar 

  • Tumova E et al (2013) The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals. J Obes 2013:729515

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Turner N et al (2007) Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56(8):2085–2092

    Google Scholar 

  • Versari D et al (2009) Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 32(Suppl 2):S312–S321

    Google Scholar 

  • Vila G et al (2011) The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem 57(2):309–316

    Article  CAS  PubMed  Google Scholar 

  • Vuong J et al (2014) Reference intervals of complete blood count constituents are highly correlated to waist circumference: should obese patients have their own “normal values?”. Am J Hematol 89(7):671–677

    Article  CAS  PubMed  Google Scholar 

  • Weil BR et al (2011) Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol 301:H689–H695

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wiedow C, Meyer-Hoffert UM (2005) Neutrophil serine protease: potential key regulators of cell signaling during inflammation. J Intern Med 257:319–328

    Article  CAS  PubMed  Google Scholar 

  • Wong HK et al (2014) Adrenomedullin and diabetes. Rev World J Diabetes 5(3):364–371

    Article  Google Scholar 

  • Xie L et al (2010) Interactive changes between macrophages and adipocytes. Clin Vaccine Immunol 17(4):651–659

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yingzhong Y, Droma Y, Rili G, Kubo K (2006) Regulation of body weight by leptin, with special reference to hypoxia-induced regulation. Intern Med 45(16):941–946

    Article  PubMed  Google Scholar 

  • Yoon JW, Jun HS (2005) Autoimmune destruction of pancreatic β cells. Am J Ther 12:580–591

    Article  PubMed  Google Scholar 

  • Younossi ZM et al (2008) A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 18:1430–1437

    Article  PubMed  Google Scholar 

  • Zhao G et al (2014) Possible role of interleukin-1b in type 2 diabetes onset and implications for anti-inflammatory therapy. PLoS Comput Biol 10(8):e1003798

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Strategic Innovation, Siemens Healthcare Diagnostics, 3400 Middlebury Street, Elkhart, IN, 46515, USA

    Michael Pugia PhD

Authors
  1. Michael Pugia PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Pugia PhD .

Editor information

Editors and Affiliations

  1. Strategic Innovation, Siemens Healthcare Diagnostics, Elkhart, Indiana, USA

    Michael Pugia

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pugia, M. (2015). Progress in New Markers for Diabetes Inflammation. In: Pugia, M. (eds) Inflammatory Pathways in Diabetes. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-21927-1_11

Download citation

Publish with us

Policies and ethics

Search

Navigation